Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Wartolowska, Karolina A.
88  Ergebnisse:
Personensuche X
?
1

Effect of blood pressure-lowering agents on microvascular f..:

Kopczak, Anna ; Stringer, Michael S ; van den Brink, Hilde...
The Lancet Neurology.  22 (2023)  11 - p. 991-1004 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Editorial: The nocebo effect and its consequences for clini..:

Wartolowska, Karolina ; Colloca, Luana ; Amanzio, Martina
Frontiers in Psychology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Low Heart Rate Is Associated with Cerebral Pulsatility afte..:

Webb, Alastair J.S. ; Wartolowska, Karolina A. ; Li, Linxin.
Annals of Neurology.  92 (2022)  6 - p. 909-920 , 2022
Link: https://doi.org/10.1002/..
 
?
4

The importance of using placebo controls in nonpharmacologi..:

Wartolowska, Karolina A. ; Hohenschurz-Schmidt, David ; Vase, Lene.
Pain.  164 (2022)  5 - p. 921-925 , 2022
Link: https://doi.org/10.1097/..
 
?
5

Aortic Stiffness, Pulse Pressure, and Cerebral Pulsatility ..:

Webb, Alastair J.S. ; Lawson, Amy ; Wartolowska, Karolina...
Stroke.  53 (2022)  4 - p. 1310-1317 , 2022
Link: https://doi.org/10.1161/..
 
?
6

The EffecTs of Amlodipine and other Blood PREssure Lowering..:

Kopczak, Anna ; Stringer, Michael S ; van den Brink, Hilde...
European Stroke Journal.  8 (2022)  1 - p. 387-397 , 2022
Link: https://doi.org/10.1177/..
 
?
7

White matter damage due to pulsatile versus steady blood pr..:

Wartolowska, Karolina A ; Webb, Alastair JS
Journal of Cerebral Blood Flow & Metabolism.  42 (2021)  5 - p. 802-810 , 2021
Link: https://doi.org/10.1177/..
 
?
8

Design of a randomised, double-blind, crossover, placebo-co..:

Webb, Alastair ; Werring, David ; Dawson, Jesse...
European Stroke Journal.  6 (2021)  3 - p. 283-290 , 2021
Link: https://doi.org/10.1177/..
 
?
9

68Ga-PSMA PET/CT and mpMRI for primary lymph node staging o..:

Yip, Ka Chun Jonathan ; Li, Yan-Lin ; Chen, Sirong..
Clinical and Translational Imaging.  9 (2021)  5 - p. 523-537 , 2021
Link: https://doi.org/10.1007/..
 
?
10

Patient-reported outcome measures (PROMs) as proof of treat..:

Kluzek, Stefan ; Dean, Benjamin ; Wartolowska, Karolina A
BMJ Evidence-Based Medicine.  27 (2021)  3 - p. 153-155 , 2021
Link: https://doi.org/10.1136/..
 
?
11

How orthopedic surgeons view open label placebo pills: Ethi..:

Bernstein, Michael H. ; Rosenfield, Maayan ; Fuchs, Nathaniel...
Journal of Psychosomatic Research.  151 (2021)  - p. 110638 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Blood Pressure Determinants of Cerebral White Matter Hyperi..:

Wartolowska, Karolina A. ; Webb, Alastair J.S.
Hypertension.  78 (2021)  2 - p. 532-539 , 2021
Link: https://doi.org/10.1161/..
 
?
13

A Higher Grey Matter Density in the Amygdala and Midbrain I..:

Lewis, Gwyn N ; Wartolowska, Karolina A ; Parker, Rosalind S...
Pain Medicine.  21 (2020)  12 - p. 3393-3400 , 2020
Link: https://doi.org/10.1093/..
 
?
14

Nocebo as a source of bias in the assessment of treatment e..:

Wartolowska, Karolina
F1000Research.  8 (2019)  - p. 5 , 2019
Link: https://doi.org/10.12688..
 
?
15

The nocebo effect as a source of bias in the assessment of ..:

Wartolowska, Karolina
F1000Research.  8 (2019)  - p. 5 , 2019
Link: https://doi.org/10.12688..
 
1-15